Use of illicit drugs during pregnancy and its risks and outcomes for mother and child - focus cannabis Pilot project CaSCH-T1

Use of illicit drugs during pregnancy and its risks and outcomes for mother and child - focus cannabis Pilot project CaSCH-T1 - CaSCH-T1

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00015730

Enrollment

250

Registered

2018-12-18

Start date

2018-12-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DSM-5: substance use disorder F10-F19

Interventions

Group 1: Pregnant women or mothers / medical qualified personnel will complete a one-time online survey.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: It is planned to receive completed questionnaires from 200 pregnant women/mothers and 50 medical qualified personnel who treat pregnant women/mothers with substance use.

Exclusion criteria

Exclusion criteria: Interested participants who do not fit in one of the below defined populations are not eligible for participation at the online survey: - Pregnant woman or mother - Physician, midwife or other medical qualified personnel who treats pregnant women/mothers with substance use

Design outcomes

Primary

Measure	Time frame
Prevalence of illicit substance use, especially cannabis, during pregnancy in Germany	—

Secondary

Measure	Time frame
State of knowledge of the target populations about risks and outcome of cannabis use during pregnancy	—

Countries

Germany

Contacts

Public ContactSabine M. Apelt

Forschungsgruppe Cannabinoide (Ltg. PD Dr. Eva Hoch) Klinik und Poliklinik für Psychiatrie und Psychotherapie Klinikum der Universität MünchenCampus Innenstadt

Sabine.Apelt@med.uni-muenchen.de+49 (0)89 4400 - 55554

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026